Source-grounded facts extracted from LENSAR, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Michael A. Rossi was appointed as Interim Chief Financial Officer at LENSAR, Inc..
“On May 25, 2026, the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) appointed Michael A. Rossi to serve as the Company’s Interim Chief Financial Officer and principal financial officer, effective as of May 29, 2026.”
LENSAR, Inc. reported the quarter ended March 31, 2026 results: revenue $13.4 million, net income $36.3 million, EPS $1.56 per basic and $0.00 per diluted share.
“quarters, now that the merger-related uncertainty is in the rear view mirror.” First Quarter 2026 Financial Results Total revenue for the quarter ended March 31, 2026 was $13.4 million, reflecting a decrease of 5% compared to t otal revenue of $14.2 million for the quarter ended March 31, 2025. The decrease was primarily attributable to decreased systems sales”
LENSAR, Inc. reported financial results for the fiscal quarter and year ended December 31, 2025.
“On March 31, 2026, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025.”
LENSAR, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. at the 2024-05-07 meeting.
“Proposal No. 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 16,568,106 134,822 301,710 0”
LENSAR, Inc. shareholders approved Election of two Class I directors to serve until the Company's annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified. at the 2024-05-07 meeting.
“Proposal No. 1 – Election of two Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes Elizabeth G. O’Farrell 13,650,553 1,705,445 1,648,640 Gary M. Winer 13,322,586 2,033,412 1,648,640”
LENSAR, Inc. reported quarter ended March 31, 2024 results: revenue $10.6 million, net income $2.2 million, EPS ($0.19) per common share.
“and staff as well as better surgical outcomes for patients, allowed us to deliver continued 20%+ revenue growth in the first quarter of 2024. Total revenue for the quarter was $10.6 million, up 28% over the first quarter of 2023. Moreover, procedure volume grew by 23% in the U.S., our largest market and the only country where ALLY is currently marketed,” said Nick”
LENSAR, Inc. reported financial results for the quarter ended December 31, 2023.
“On March 4, 2024, LENSAR, Inc. (the “Company”) issued a press release announcing financial results for the fiscal quarter ended December 31, 2023.”
LENSAR, Inc. reported fiscal quarter ended September 30, 2023 results: revenue $9.8 million, net income $2.6 million, EPS $0.13.
“Total revenue for the quarter ended September 30, 2023 was $9.8 million, an increase of $2.1 million, or 26%, compared to total revenue of $7.7 million for the quarter ended September 30, 2022.”
John P. McLaughlin departed as Director at LENSAR, Inc..
“On October 9, 2023, John P. McLaughlin notified the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) of his intent to retire from the Board, effective October 31, 2023.”
LENSAR, Inc. reported the quarter ended June 30, 2023 results: revenue $12.0 million, net income $8.8 million, EPS ($0.81) per share.
“Total revenue for the quarter ended June 30, 2023 was $12.0 million, an increase of $4.0 million, or 49%, compared to total revenue of $8.0 million for the quarter ended June 30, 2022.”
LENSAR, Inc. shareholders approved Approval of issuance of shares upon conversion of Series A convertible preferred stock and exercise of warrants at the 2023-08-01 meeting.
“Proposal 1 – Approval, pursuant to Nasdaq Listing Rule 5635(b), of the issuance of shares of the Company’s common stock upon conversion of shares of Series A convertible preferred stock and exercise of warrants designated as the Class A Common Stock Purchase Warrants and warrants designated as the Class B Common Stock Purchase Warrants issued and sold to an affiliate of North Run Capital, LP.”
LENSAR, Inc. shareholders approved Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023. at the 2023-05-25 meeting.
“Item 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 8,602,158 229,157 86,005 0”
LENSAR, Inc. shareholders approved Election of two Class III directors to serve until the Company's annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. at the 2023-05-25 meeting.
“Item 1 – Election of two Class III directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified. Votes FOR Votes WITHHELD Broker Non-Votes William J. Link, PhD 5,883,023 1,117,236 1,917,061 Richard L. Lindstrom, MD 5,910,865 1,089,394 1,917,061”
LENSAR, Inc. entered into Securities Purchase Agreement with NR-GRI Partners, LP valued at $20,000,000 (effective 2023-05-18).
“As previously disclosed, on May 12, 2023, LENSAR, Inc. (the “ Compan y ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with NR-GRI Partners, LP, a Delaware limited partnership and an affiliate of North Run Capital, LP (the “ Buyer ”), whereby it agreed to sell to the Buyer, for an aggregate gross purchase price of $20.0 million, (i) an aggregate of 20,000 shares of a newly established series of Preferred Stock designated as “Series A Convertible Preferred Stock, par value $0.01 per share” (the “ Preferred Shares ”), which have a stated value of $1,000 per share and are initially convertible into 7,940,446 shares (the “ Conversion Shares ”) of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”), subject to certain beneficial ownership limitations described below and (ii) warrants (the “ Warrants ”) to purchase an aggregate of 4,367,246 shares of Common Stock (the “ Warrant Shares ”).”
LENSAR, Inc. reported the quarter ended March 31, 2023 results: revenue $8.3 million, net income $4.3 million, EPS ($0.40) per share.
“Total revenue for the quarter ended March 31, 2023 was $8.3 million, a decrease of $1.1 million, or 12%, compared to total revenue of $9.3 million for the quarter ended March 31, 2022.”
LENSAR, Inc. entered into Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock with NR-GRI Partners, LP valued at Establishes rights, preferences, and conversion terms for Series A Convertible Preferred Stock, incl (effective 2023-05-12).
“As provided in the Purchase Agreement, before the closing of the Offering, the Company will file with the Secretary of State of the State of Delaware a Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock (the “ Certificate of Designations ”) to its Amended and Restated Certificate of Incorporation.”
LENSAR, Inc. entered into Securities Purchase Agreement with NR-GRI Partners, LP valued at Aggregate gross purchase price of $20,000,000 for 20,000 shares of Series A Convertible Preferred St (effective 2023-05-12).
“On May 12, 2023, LENSAR, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with NR-GRI Partners, LP, a Delaware limited partnership and an affiliate of North Run Capital, LP (the “ Buyer ”), whereby it agreed to sell to the Buyer, for an aggregate gross purchase price of $20.0 million, (i) an aggregate of 20,000 shares of a newly established series of Preferred Stock designated as “Series A Convertible Preferred Stock, par value $0.01 per share” (the “ Preferred Shares ”), which have a stated value of $1,000 per share and are initially convertible into 7,940,446 shares (the “ Conversion Shares ”) of the Company’s common stock, par value $0.01 per share (the “ Common Stock ”), subject to the Ownership Blocker (as defined below), and (ii) warrants (the “ Warrants ”) to purchase an aggregate of 4,367,246 shares of Common Stock (the “ Warrant Shares ”).”
Todd B. Hammer was appointed as Director at LENSAR, Inc..
“Also on May 12, 2023, in connection with the Offering and pursuant to the Purchase Agreement and subject to the closing of the Offering, the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board effective immediately following the 2023 Annual Meeting of Stockholders.”
Thomas B. Ellis was appointed as Director at LENSAR, Inc..
“Also on May 12, 2023, in connection with the Offering and pursuant to the Purchase Agreement and subject to the closing of the Offering, the Board appointed each of Thomas B. Ellis and Todd B. Hammer to the Board effective immediately following the 2023 Annual Meeting of Stockholders.”
LENSAR, Inc. reported the quarter ended December 31, 2022 results: revenue $10.2 million, net income $2.5 million, or ($0.24) per share, EPS ($0.24) per share.
“and so accurate that I have added at least 3 to 4 cases onto my surgery days." Fourth Quarter 2022 Financial Results Total revenue for the quarter ended December 31, 2022 was $10.2 million, a decrease of $1.0 million, or 9%, compared to total revenue of $11.2 million for the quarter ended December 31, 2021. The decrease from the fourth quarter of 2021 was primarily”
LENSAR, Inc. reported the fiscal quarter and year ended December 31, 2022 results: revenue Total revenue for the quarter ended December 31, 2022 was approximately $10.2 million; Total revenue for the year ended.
“On February 14, 2023, LENSAR, Inc. (the “Company”) issued a press release announcing preliminary unaudited results for the fiscal quarter and year ended December 31, 2022.”
LENSAR, Inc. reported the quarter ended September 30, 2022 results: revenue $7.7 million, net income $4.0 million, or ($0.39) per share.
“with 2.5 - 3 minutes when using prior generation and competitive technologies.” Third Quarter 2022 Financial Results Total revenue for the quarter ended September 30, 2022 was $7.7 million, a decrease of $0.5 million, or 6%, compared to total revenue of $8.3 million for the quarter ended September 30, 2021. The decrease in third quarter 2022 revenue was associated”
Kendra W. Wong was appointed as Principal Accounting Officer at LENSAR, Inc..
“On January 11, 2022, the Board of Directors (the “Board”) of LENSAR, Inc. (the “Company”) appointed Kendra W. Wong, previously the Company’s Director of Financial Operations, to serve as the Company’s Principal Accounting Officer, effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.